153 related articles for article (PubMed ID: 29635632)
21. A retrospective comparison of intrathecal morphine and epidural hydromorphone for analgesia following posterior spinal fusion in adolescents with idiopathic scoliosis.
Hong RA; Gibbons KM; Li GY; Holman A; Voepel-Lewis T
Paediatr Anaesth; 2017 Jan; 27(1):91-97. PubMed ID: 27878902
[TBL] [Abstract][Full Text] [Related]
22. Preemptive analgesia for postoperative pain relief in thoracolumbosacral spine operations: a double-blind, placebo-controlled randomized trial.
Aglio LS; Abd-El-Barr MM; Orhurhu V; Kim GY; Zhou J; Gugino LD; Crossley LJ; Gosnell JL; Chi JH; Groff MW
J Neurosurg Spine; 2018 Dec; 29(6):647-653. PubMed ID: 30215593
[TBL] [Abstract][Full Text] [Related]
23. [New Opioid Options in Japan - Methadone, Tapentadol and Hydromorphone].
Takagi Y; Aruga E
Gan To Kagaku Ryoho; 2018 Feb; 45(2):205-211. PubMed ID: 29483406
[TBL] [Abstract][Full Text] [Related]
24. Intrathecal Morphine versus Intrathecal Hydromorphone for Analgesia after Cesarean Delivery: A Randomized Clinical Trial.
Sharpe EE; Molitor RJ; Arendt KW; Torbenson VE; Olsen DA; Johnson RL; Schroeder DR; Jacob AK; Niesen AD; Sviggum HP
Anesthesiology; 2020 Jun; 132(6):1382-1391. PubMed ID: 32251031
[TBL] [Abstract][Full Text] [Related]
25. Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone.
Ward A; Bozkaya D; Fleischmann J; Dubois D; Sabatowski R; Caro JJ
Curr Med Res Opin; 2007 Oct; 23(10):2333-45. PubMed ID: 17697453
[TBL] [Abstract][Full Text] [Related]
26. Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine.
Bruera E; Pereira J; Watanabe S; Belzile M; Kuehn N; Hanson J
Cancer; 1996 Aug; 78(4):852-7. PubMed ID: 8756381
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis.
Hale M; Tudor IC; Khanna S; Thipphawong J
Clin Ther; 2007 May; 29(5):874-888. PubMed ID: 17697906
[TBL] [Abstract][Full Text] [Related]
28. The side effects of morphine and hydromorphone patient-controlled analgesia.
Hong D; Flood P; Diaz G
Anesth Analg; 2008 Oct; 107(4):1384-9. PubMed ID: 18806056
[TBL] [Abstract][Full Text] [Related]
29. Dose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective study.
Lawlor P; Turner K; Hanson J; Bruera E
Pain; 1997 Aug; 72(1-2):79-85. PubMed ID: 9272790
[TBL] [Abstract][Full Text] [Related]
30. Morphine and hydromorphone-induced hyperalgesia in a hospice patient.
Juba KM; Wahler RG; Daron SM
J Palliat Med; 2013 Jul; 16(7):809-12. PubMed ID: 22925158
[TBL] [Abstract][Full Text] [Related]
31. [The role of hydromorphone in pain killing].
Telekes A
Lege Artis Med; 2008 Oct; 18(10):675-9. PubMed ID: 19227610
[TBL] [Abstract][Full Text] [Related]
32. Do Types of Opioids Matter for Terminal Cancer Dyspnea? A Preliminary Multicenter Cohort Study.
Mori M; Yamaguchi T; Suzuki K; Matsuda Y; Matsunuma R; Watanabe H; Ikari T; Matsumoto Y; Imai K; Yokomichi N; Miwa S; Yamauchi T; Okamoto S; Inoue S; Inoue A; Hui D; Morita T; Satomi E;
J Pain Symptom Manage; 2023 Aug; 66(2):e177-e184. PubMed ID: 37080479
[TBL] [Abstract][Full Text] [Related]
33. A randomized, double-blind comparison of OROS(R) hydromorphone and controlled-release morphine for the control of chronic cancer pain.
Hanna M; Thipphawong J;
BMC Palliat Care; 2008 Oct; 7():17. PubMed ID: 18976472
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of a new once daily hydromorphone formulation in comparison with twice daily administration in chronic pain: a randomized, double-blind, cross-over study.
Nold GE; Maritz MA; Schwittay A; Schumann C; Rey H
Curr Med Res Opin; 2016 May; 32(5):869-77. PubMed ID: 26824884
[TBL] [Abstract][Full Text] [Related]
35. Intravenous methadone for cancer pain unrelieved by morphine and hydromorphone: clinical observations.
Manfredi PL; Borsook D; Chandler SW; Payne R
Pain; 1997 Mar; 70(1):99-101. PubMed ID: 9106815
[TBL] [Abstract][Full Text] [Related]
36. Comparative clinical effects of hydromorphone and morphine: a meta-analysis.
Felden L; Walter C; Harder S; Treede RD; Kayser H; Drover D; Geisslinger G; Lötsch J
Br J Anaesth; 2011 Sep; 107(3):319-28. PubMed ID: 21841049
[TBL] [Abstract][Full Text] [Related]
37. Intrathecal Hydromorphone and Morphine for Postcesarean Delivery Analgesia: Determination of the ED90 Using a Sequential Allocation Biased-Coin Method.
Sviggum HP; Arendt KW; Jacob AK; Niesen AD; Johnson RL; Schroeder DR; Tien M; Mantilla CB
Anesth Analg; 2016 Sep; 123(3):690-7. PubMed ID: 26974022
[TBL] [Abstract][Full Text] [Related]
38. Hydromorphone: evolving to meet the challenges of today's health care environment.
Gregory TB
Clin Ther; 2013 Dec; 35(12):2007-27. PubMed ID: 24290733
[TBL] [Abstract][Full Text] [Related]
39. Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR).
Coluzzi PH; Schwartzberg L; Conroy JD; Charapata S; Gay M; Busch MA; Chavez J; Ashley J; Lebo D; McCracken M; Portenoy RK
Pain; 2001 Mar; 91(1-2):123-30. PubMed ID: 11240084
[TBL] [Abstract][Full Text] [Related]
40. Comparing the subjective, psychomotor, and physiological effects of intravenous hydromorphone and morphine in healthy volunteers.
Hill JL; Zacny JP
Psychopharmacology (Berl); 2000 Sep; 152(1):31-9. PubMed ID: 11041313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
